Inventor · disambiguated record
Valina L. Dawson
Also filed as: DAWSON VALINA · DAWSON VALINA L
12 granted patents·10 pending applications·321 citations·filing 1992–2022
90Inventor score
Top patents by PatentIndex Score
22 records- 0192US5587384AInhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicityUNIV JOHNS HOPKINS·Filed 1994·Granted Dec 24, 1996·109 cites·20 claims
- 0290USRE36397EInhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicityUNIV JOHNS HOPKINS·Filed 1998·Granted Nov 16, 1999·87 cites·4 claims
- 0388US6358975B1Method of using selective parp inhibitors to prevent or treat neurotoxicityUNIV JOHNS HOPKINS·Filed 2000·Granted Mar 19, 2002·43 cites·7 claims
- 0478US8603994B2Transcriptional repression leading to Parkinson's diseaseDAWSON TED M·Filed 2011·Granted Dec 10, 2013·3 cites·9 claims
- 0578US5266594AInhibitors of nitric oxide synthase and use thereof to prevent glutamate neurotoxicityDAWSON VALINA L·Filed 1992·Granted Nov 30, 1993·65 cites·18 claims
- 0666US12276657B2Detection of PAR in the CSF of patients with Parkinson's diseaseUNIV JOHNS HOPKINS·Filed 2022·Granted Apr 15, 2025·0 cites·10 claims
- 0766US12233109B2Long-acting GLP-1r agonist as a therapy of neurological and neurodegenerative conditionsUNIV JOHNS HOPKINS·Filed 2021·Granted Feb 25, 2025·0 cites·32 claims
- 0861US8921042B2Transcriptional repression leading to Parkinson's diseaseVALTED LLC·Filed 2013·Granted Dec 30, 2014·0 cites·3 claims
- 0960US2022249597A1Mif inhibitors and methods of use thereofUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 1059US9274128B2Transcriptional repression leading to parkinson's diseaseVALTED LLC·Filed 2014·Granted Mar 1, 2016·0 cites·3 claims
- 1159US2023012209A1Methods of preventing or treating parkinson's disease by the farnesylation of parisUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 1256US11123405B2Long-acting GLP-1R agonist as a therapy of neurological and neurodegenerative conditionsUNIV JOHNS HOPKINS·Filed 2016·Granted Sep 21, 2021·0 cites·33 claims
- 1351US2021148898A1Detection of par in the csf of patients with parkinson's diseaseUNIV JOHNS HOPKINS·Filed 2018·Application pending·0 cites
- 1450US6362160B1Immunophilin-binding agents prevent glutamate neurotoxicity associated with vascular stroke and neurodegenerative diseasesUNIV JOHNS HOPKINS MED·Filed 1993·Granted Mar 26, 2002·14 cites·18 claims
- 1547US2022372014A1Neuroprotective compounds and methods of use thereofUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 1644US2019224274A1Mif inhibitors and methods of use thereofUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 1743US2022291240A1Biomarkers for neurodegenerative disordersUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 1842US2019117586A1Methods of preventing or treating parkinson's disease by the farnesylation of parisUNIV JOHNS HOPKINS·Filed 2018·Application pending·0 cites
- 1940US2019194324A1THERAPEUTIC USES OF LAG3 THE (alpha)-SYNUCLEIN TRANSMISSION RECEPTORUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 2038US2015018301A1LRRK-2-Mediated Neuronal ToxicityLEE BYOUNG DAE·Filed 2010·Application pending·0 cites
- 2135US9623039B2Treatment and prevention of pathological conditions using iduna related techniques and compositionsDAWSON TED M·Filed 2011·Granted Apr 18, 2017·0 cites·1 claims
- 2230US2012122765A1Compounds and related methods for manipulating parp-1-dependent cell deathDAWSON TED M·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Valina L. Dawson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →